Challenges and Controversies in the Surgical Treatment of Cervical Cancer: Open Radical Hysterectomy versus Minimally Invasive Radical Hysterectomy
Authors:
- Jona RöselerJRJona Röseler
- Robert WolffRWRobert Wolff
- Dirk O. BauerschlagDBDirk O. Bauerschlag
- Nicolai MaassNMNicolai Maass
- Peter HillemannsPHPeter Hillemanns
- Helder FerreiraHFHelder Ferreira
- Marie DebrouwereMDMarie Debrouwere
- Fülöp ScheiblerFSFülöp Scheibler
- Friedemann GeigerFGFriedemann Geiger
- Mohamed ElessawyMEMohamed Elessawy
Open Access
- 24 August 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (17) , 3761
Abstract
Objective: The aim of the study was to perform a systematic assessment of disease-free survival (DFS), overall survival, and morbidity rates after open radical hysterectomy (ORH) and minimally invasive surgery (MIS) for early-stage cervical cancer and discuss with experts the consequences of the LACC trial (published by Ramirez et al. in 2018) on clinical routine. Methods: A total of 5428 records were retrieved. After exclusion based on text screening, four records were identified for inclusion. Five experts from three independent large-volume medical centers in Europe were interviewed for their interpretation of the LACC trial. Results: The LACC trial showed a significantly higher risk of disease progression with MIS compared to ORH (HR 3.74, 95% CI 1.63 to 8.58). This was not seen in one epidemiological study and was contradicted by one prospective cohort study reported by Greggi et al. A systematic review by Zhang et al. mentioned a similar DFS for robot-assisted radical hysterectomy (RRH) and LRH. Recurrence rates were significantly higher with MIS compared to ORH in the LACC trial (HR 4.26, 95% CI 1.44 to 12.60). In contrast, four studies presented by Greggi reported no significant difference in recurrence rates between LRH/RRH and ORH, which concurred with the systematic reviews of Zhang and Zhao. The experts mentioned various limitations of the LACC trial and stated that clinicians were obliged to provide patients with detailed information and ensure a shared decision-making process. Conclusions: The surgical treatment of early-stage cervical cancer remains a debated issue. More randomized controlled trials (RCT) will be needed to establish the most suitable treatment for this condition.Keywords
This publication has 30 references indexed in Scilit:
- ROBIS: A new tool to assess risk of bias in systematic reviews was developedJournal of Clinical Epidemiology, 2016
- Soft‐tissue re‐growth following fibre retention osseous resective surgery or osseous resective surgery: a multilevel analysisJournal of Clinical Periodontology, 2015
- Comparison of Laparoscopic-Assisted Radical Vaginal Hysterectomy and Laparoscopic Radical Hysterectomy in the Treatment of Cervical CancerAnnals of Surgical Oncology, 2012
- Recurrence and Survival After Random Assignment to Laparoscopy Versus Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group LAP2 StudyJournal of Clinical Oncology, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLOS Medicine, 2009
- Laparoscopic Colectomy for Cancer Is Not Inferior to Open Surgery Based on 5-Year Data From the COST Study Group TrialAnnals of Surgery, 2007
- Laparoscopic Versus Open Subtotal Gastrectomy for Distal Gastric CancerAnnals of Surgery, 2005
- A Comparison of Laparoscopically Assisted and Open Colectomy for Colon CancerNew England Journal of Medicine, 2004
- Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trialThe Lancet, 2002